Combined immunotherapy in melanoma patients with brain metastases: A multicenter international study

Ipilimumab plus nivolumab (COMBO) is the standard treatment in asymptomatic patients with melanoma brain metastases (MBM). We report a retrospective study aiming to assess the outcome of patients with MBM treated with COMBO outside clinical trials. Consecutive patients treated with COMBO have been i...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European journal of cancer (1990) 2024-03, Vol.199, p.113542-113542, Article 113542
Hauptverfasser:	Mandalà, Mario, Lorigan, Paul, Sergi, Maria Chiara, Benannoune, Naima, Serra, Patricio, Vitale, Maria Grazia, Giannarelli, Diana, Arance, Ana Maria, Couselo, Eva Munoz, Neyns, Bart, Tucci, Marco, Guida, Michele, Spagnolo, Francesco, Rossi, Ernesto, Occelli, Marcella, Queirolo, Paola, Quaglino, Pietro, Depenni, Roberta, Merelli, Barbara, Placzke, Joanna, Di Giacomo, Anna Maria, del Vecchio, Michele, Indini, Alice, da Silva, Ines Pires, Menzies, Alexander M., Long, Georgina V., Robert, Caroline, Rutkowski, Piotr, Ascierto, Paolo A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Brain metastases Combined immunotherapy Melanoma Prognosis Stereotactic radiosurgery
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!